- Report
- May 2024
- 129 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
Amebiasis is an infection caused by a parasite, and is one of the most common infectious diseases worldwide. Treatment for amebiasis typically involves the use of drugs, such as metronidazole, tinidazole, and iodoquinol. These drugs are used to kill the parasite and reduce symptoms. In some cases, a combination of drugs may be used to treat the infection.
Infectious diseases drugs are a major market, with a wide range of products available to treat a variety of conditions. Amebiasis drugs are a subset of this market, and are used to treat the infection caused by the parasite. These drugs are typically available in both oral and injectable forms, and are used to kill the parasite and reduce symptoms.
Some companies in the Amebiasis Drug market include Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, Sanofi, and Johnson & Johnson. Show Less Read more